logo
Canned tuna sold at Walmart, Costco, and Trader Joe's is being recalled over botulism fears

Canned tuna sold at Walmart, Costco, and Trader Joe's is being recalled over botulism fears

Yahoo11-02-2025

Several brands of canned tuna, sold at Trader Joe's, Costco (COST), and Walmart (WMT) locations across the country, have been recalled over concerns of clostridium botulinum, a bacterium that can produce a fatal neurotoxin.
Tri-Union, a California-based subsidiary of the global seafood provider Thai Union, has issued a voluntary recall of some of its canned tuna products, according to an alert from the U.S. Food and Drug Administration (FDA) on Monday.
Tri-Union, said the recall was issued 'out of an abundance of caution' after a supplier notified the company that the 'easy open' pull tab can lid that is used on a limited number of its products had a manufacturing defect that could cause it to leak or be contaminated with clostridium botulinum. The recall affects 13 products sold in at least 26 states and Washington D.C.
The FDA warned consumers not to use the recalled products 'even if it does not look or smell spoiled' and that consumers that feel unwell should seek immediate medical attention. So far, no illnesses linked with the recalled products have been reported.
Genova Solid White Tuna in Olive Oil 5.0 oz
Genova Yellowfin Tuna in Olive Oil 5.0 oz
Genova Yellowfin Tuna in Olive Oil 5.0 oz 4 Pack
Genova Yellowfin Tuna in Olive Oil 7.0 oz 6 Pack
Genova Yellowfin Tuna in in Extra Virgin Olive Oil with Sea Salt 5.0 oz
Van Camp's Solid Light Tuna in Oil 5.0 oz
Van Camp's Solid Light Tuna in Oil 5 oz 4 Pack
Trader Joe's Solid Light Yellowfin Tuna in Olive Oil
Trader Joe's Solid White Tuna in Olive Oil
Trader Joe's Solid White Tuna in Water
Trader Joe's Solid White Water Low Sodium
Trader Joe's Solid White Water No Salt Added
H-E-B Solid White Tuna in Water 5.0 oz 4 Pack
A full list of recalled products including UPC codes, can codes and best-if-used-by dates can be found here.
Clostridium botulinum can produce a toxin that attacks the body's nerves and can lead to botulism, an illness that causes breathing complications, muscle paralysis, and death, according to the U.S. Centers for Disease Control and Prevention.
For the latest news, Facebook, Twitter and Instagram.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Breyers Ice Creams Recalled After Flavor Containing Life-Threatening Allergen Was Packaged as Another Flavor
Breyers Ice Creams Recalled After Flavor Containing Life-Threatening Allergen Was Packaged as Another Flavor

Yahoo

time9 minutes ago

  • Yahoo

Breyers Ice Creams Recalled After Flavor Containing Life-Threatening Allergen Was Packaged as Another Flavor

6,668 cases of Breyers Chocolate Truffle Ice Cream across the United States have been recalled by Unilever Manufacturing The affected ice cream cartons actually contain Rocky Road Ice Cream, which contains almonds, a potentially "life-threatening" allergen The U.S. Food and Drug Administration announced the recall on June 10Over 6,600 cases of Breyers Ice Cream have been recalled amid concerns that the product is mislabeled and contains a "life-threatening" allergen. The U.S. Food and Drug Administration confirmed that 6,668 cases of Breyers Chocolate Truffle Ice Cream were voluntarily recalled by Unilever Manufacturing on June 2 in a Tuesday, June 10 statement. The cause for the recall was determined to be "undeclared allergens and mislabeled product." "Rocky Road Ice was packaged with Chocolate Truffle Ice Cream labeled tub and a Rocky Road Ice Cream lid. Tub said 'may contain tree nuts' the lid said it did contain almonds," the FDA clarified about the recall. is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! The FDA declared this a Class II recall, which is defined as "a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." A representative for Breyers commented on the recall in a statement shared with PEOPLE, saying, "Unilever in the U.S. is voluntarily recalling one lot of Breyers Chocolate Truffle 1.5 quart tubs after some were found to contain Rocky Road ice cream, which includes almonds not listed on the label." The statement continued: "People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction. The safety and quality of our products is our top priority. For more information, consumers can visit or call 1-800-931-2826." It is unclear where exactly the cases of ice cream were distributed across the United States. The FDA reported the distribution as targeting "distribution centers and retail locations across the U.S." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories. Rocky Road is a flavor of ice cream that contains almonds. Although almonds are considered tree nuts, the label for Breyers Chocolate Truffle Ice Cream only says that the product "may contain tree nuts." The Breyers recall comes a few weeks after nearly 18,000 containers of Wells Dairy ice cream and frozen yogurt were recalled due to contamination with hard plastics. Wells Enterprises, which produces Wells Dairy products, was responsible for the recall, which targeted 22 different flavors of frozen desserts. Read the original article on People

Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management
Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management

Yahoo

time15 minutes ago

  • Yahoo

Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management

Experts from Stormont Vail Health will share achievements using MCG artificial intelligence to improve hospital revenue cycle DENVER, June 12, 2025 /PRNewswire/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces three of its hospital client partners from Topeka-based Stormont Vail Health will present at the HFMA Annual Conference happening June 22-25, 2025, in Denver, Colorado. The HFMA event is widely known for bringing together over 4,000 healthcare finance professionals to share new strategies, best practices, and valuable resources. Stormont Vail's VP Quality and Population Health, Chad Yeager, MSN, RN; Medical Director of Utilization Review and Physician Advisor, Sri Suravarapu, MD; and System Director of the Revenue Cycle, William "Bill" Lane, BS, CHFP, will present the session, "Utilizing AI and Automation to Streamline Utilization Review and Protect Hospital Revenue," on Tuesday, June 24, 2025, from 2:00 p.m. to 2:25 p.m. MDT. This presentation will cover several topics including: How MCG Indicia software (enhanced with AI capabilities) has improved medical necessity documentation and increased hospital staff efficiency The sources of EHR data that are beneficial in determining medical necessity and priority for patient admissions Opportunities to improve existing medical necessity documentation workflows within a hospital EHR platform "AI has revolutionized how we approach utilization review, enabling our teams to streamline processes and focus on high-value tasks," said Chad Yeager, MSN, RN. "At the HFMA 2025 Conference, we'll share how these innovative AI tools not only enhanced our staff's productivity but also significantly improved the quality of patient care, ensuring swift and appropriate admission decisions upfront while maximizing our hospital's operational efficiency." "By leveraging the natural language processing features of MCG Indicia Synapse, we've been able to protect our hospital's revenue cycle while simultaneously reducing administrative burdens on our staff," said Sri Suravarapu, MD. "Our presentation will showcase practical strategies and results, offering actionable insights for hospital leaders eager to optimize their workflows, drive evidence-based patient care, and stay ahead of the curve in a rapidly evolving healthcare landscape." For those interested in attending the annual HFMA Conference, registration details and additional information can be found at About Stormont Vail HealthStormont Vail Health is a nonprofit integrated health system that has served the healthcare needs of Kansas for more than 130 years. Stormont Vail has been recognized as a Magnet® organization since 2009 by the American Nurses Credentialing Center. It is composed of Stormont Vail Hospital in Topeka, a 586-bed acute care hospital, Stormont Vail Flint Hills Hospital in Junction City, a 92-bed acute care hospital, Stormont Vail Health Manhattan Campus, a primary care, specialty care, and imaging clinic, and Cotton O'Neil Clinic, a multi-specialty physician group with more than 500 providers, including more than 270 physicians. Learn more at About MCG HealthMCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG's artificial intelligence and technology, infused with clinical expertise, enable its clients to prioritize and simplify their work. MCG's world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit About Hearst HealthThe mission of Hearst Health is to guide healthcare organizations by delivering essential intelligence and software that improve the quality, safety and efficiency of care. Hearst Health has been innovating with care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies — FDB, Homecare Homebase, MCG, MHK, QGenda and Zynx Health — elevate care by informing and empowering participants across the health journey. To learn more, visit and follow @Hearst Health on LinkedIn. View original content to download multimedia: SOURCE MCG Health Sign in to access your portfolio

Exoskeleton Market Research and Global Forecast Report 2025-2030: Powered Exoskeletons Lead Growth with Robust Investment Activities, Industrial Adoption Amplifies Expansion
Exoskeleton Market Research and Global Forecast Report 2025-2030: Powered Exoskeletons Lead Growth with Robust Investment Activities, Industrial Adoption Amplifies Expansion

Yahoo

time18 minutes ago

  • Yahoo

Exoskeleton Market Research and Global Forecast Report 2025-2030: Powered Exoskeletons Lead Growth with Robust Investment Activities, Industrial Adoption Amplifies Expansion

The exoskeleton market is projected to grow from USD 0.56 billion in 2025 to USD 2.03 billion by 2030, with a CAGR of 29.4%. Exoskeletons enhance mobility for those with physical impairments and reduce industrial workers' strain, boosting demand in healthcare and manufacturing. The rise in the elderly population and home rehabilitation heightens this need. Technological advancements, including AI and improved materials, are enhancing exoskeleton functionality and availability. Significant investments, such as those in German Bionic and Verve Motion, highlight the industry's growth potential. Key players include Ekso Bionics, Ottobock, and CYBERDYNE Inc. Exoskeleton Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Exoskeleton Market by Component (Sensors, Actuators, Power Systems, Controllers, Software), Functionality (Assistive, Rehabilitative, Augmentative, Preventive), Type (Powered, Passive, Hybrid), Body Part (Lower, Upper, Full Body) - Global Forecast to 2030" has been added to offering. The exoskeleton market is anticipated to grow significantly, from USD 0.56 billion in 2025 to USD 2.03 billion by 2030, with a robust CAGR of 29.4% This surge is driven by its expanding integration into healthcare and manufacturing sectors, aiding mobility for physically impaired individuals while reducing industrial workers' physical strain. An aging population and increased home care rehabilitation further propel the demand. The evolution of technology, including AI, sensors, and lightweight materials, enhances the affordability, accessibility, and performance of exoskeletons. Investment from both public and private sectors will continue to bolster product innovation and market growth. Key players in the market include Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), among Exoskeletons Gaining Momentum The powered exoskeleton sector is witnessing robust growth, exemplified by the strategic investments and increased investor confidence in its commercial viability. German Bionic, an innovator in electrically powered exoskeletons, secured over USD 16.3 million in an extended Series A funding round in December 2023. This investment aims to enhance collaboration with Mubea and scale production for better market deployment. Additionally, Verve Motion, a Cambridge-based startup specializing in robotic exosuits, raised USD 20 million in a Series B funding round to further its market reach. These developments highlight the strategic investment in powered exoskeleton technology, poised to revolutionize industrial automation, injury prevention, and workforce Sector's Rapid Adoption The industrial sector is increasingly adopting exoskeletons to boost worker safety, mitigate fatigue, and enhance productivity. They are essential in industries such as manufacturing, logistics, and assembly lines, where repetitive tasks are prevalent. Exoskeletons help mitigate musculoskeletal injuries by supporting the lower back, shoulders, and legs, thereby reducing the occupational health costs and improving Leading Europe Germany leads the European exoskeleton market with strong industrial demand and innovation in healthcare, supported by significant private investments. Its robust manufacturing and logistics sectors actively integrate exoskeletons to enhance workforce efficiency and reduce musculoskeletal injuries. Companies like German Bionic are at the forefront, raising over USD 16.3 million to advance their product offerings, with models like Apogee and Apogee+ significantly impacting logistics, retail, and healthcare sectors with their ergonomic Insights Include: Analysis of market drivers, restraints, opportunities, and challenges. Insights into upcoming technologies, R&D activities, and product launches. Comprehensive information on lucrative markets. In-depth competitive assessments and strategic analysis of leading players. Key Attributes: Report Attribute Details No. of Pages 255 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $0.56 Billion Forecasted Market Value (USD) by 2030 $2.03 Billion Compound Annual Growth Rate 29.4% Regions Covered Global Market Dynamics Drivers Rising Demand for Robotic Rehabilitation Solutions From Healthcare Sector Increased Adoption in Industrial and Manufacturing Sectors Increased FDA Approvals for Medical Exoskeletons Challenges High Cost of Ownership Comfort and Movement Interference for Workers Power Supply Limitations and Operational Downtime Opportunities Integration of Exoskeletons With AI and IoT Technologies Increasing Adoption of Exoskeletons in Military and Defense Sectors Case Studies Enhancing Worker Ergonomics and Productivity At John Deere With Comau's Mate-Xt Wearable Exoskeleton Enhancing Logistics Operations and Worker Well-Being At Fiege Group With German Bionic AI-Powered Exoskeleton Technology Enhancing Worker Safety and Productivity in Tunnel Construction At Granite Construction With Levitate Technologies Exoskeletons Reducing Physical Strain in Truck Maintenance At Man Truck & Bus With Help of Suitx Technology by Ottobock Ford Motor Company Enhances Worker Safety and Reduces Injuries With Ekso Bionics Eksovest Company Profiles Ekso Bionics Ottobock DIH Medical Comau Myomo Inc. Cyberdyne Inc. Lifeward Ltd. Hyundai Motor Group Robotics Lab. B-Temia Rex Bionics Ltd. Able Human Motion Laevo Exoskeletons German Bionic Systems GmbH Levitate Technologies, Inc. Fourier Trexo Robotics Wandercraft Agade Europe Technologies Archelis Inc. P&S Mechanics Co., Ltd. Rb3D Japet Medical Devices Proteso S.R.L. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Exoskeleton Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store